Effects of Apigenin, an Antioxidant, on the Bioavailability and Pharmacokinetics of Etoposide
|
|
Lim, Tea-Hwan
(Department of Pharmacy, Chosun University Hospital)
Park, Sun-Hee (Department of Pharmacy, Chosun University Hospital) Choi, Jun-Shik (College of Pharmacy, Chosun University) |
| 1 | Dixon RA, Steele CL. Flavonoids and isoflavonoids - a gold mine for metabolic engineering. Trends Plant Sci 1999; 4: 394-400. DOI ScienceOn |
| 2 | Stahelin HF, von Wartburg A. The chemical and biological route from podophyllotoxin glucoside to etoposide: Ninth Cain memorial award lecture. Cancer Res 1991; 51: 5-15. |
| 3 | Clark PI, Slevin ML. The clinical pharmacology of etoposide and teniposide. Clin Pharmacokinet 1987; 12: 223-252. DOI ScienceOn |
| 4 | Wozniak AJ, Ross WE. DNA damage as a basis for 4'- demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-Dglucopyranoside) (etoposide) cytotoxicity. Cancer Res 1983; 43: 120-124. |
| 5 | van Maanen JM, de Vries J, Pappie D. Cytochrome P- 450-mediated O-demethylation: a route in the metabolic activation of etoposide (VP-16-213). Cancer Res 1987; 47: 4658-4662. |
| 6 | Relling MV, Nemec J, Schuetz EG, et al., Odemethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4. Mol Pharmacol 1994; 45: 352-358. |
| 7 | Kawashiro T, Yamashita K, Zhao XJ, et al., A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes. J Pharmacol Exp Ther 1998; 286: 1294- 1300. |
| 8 | Leu BL, Huang JD. Inhibition of intestinal P-glycoprotein and effects on etoposide absorption. Cancer Chemother Pharmacol 1995; 35: 432-436. DOI ScienceOn |
| 9 | Carcel-Trullols J, Torres-Molina F, Araico A, et al., Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide. Cancer Chemother Pharmacol 2004; 54: 153- 160. |
| 10 | Keller RP, Altermatt HJ, Donatsch P, et al., Pharmacologic interactions between the resistance-modifying cyclosporine SDZ PSC 833 and etoposide (VP 16-213) enhance in vivo cytostatic activity and toxicity. Int J Cancer 1992; 51: 433- 438. DOI |
| 11 | Yin Y, Gong FY, Wu XX, et al., Anti-inflammatory and immunosuppressive effect of flavones isolated from Artemisia vestita. J Ethnopharmacol 2008; 120: 1-6. DOI ScienceOn |
| 12 | Nafisi S, Hashemi M, Rajabi M. DNA Adducts with Antioxidant Flavonoids: Morin, Apigenin, and Naringin. DNA and Cell Biology 2008; 27: 1-10. DOI ScienceOn |
| 13 | Galati G, Moridani MY, Chan TS, et al., Peroxidative metabolism of apigenin and naringenin versus luteolin and quercetin: glutathione oxidation and conjugation. Free Radical Biology & Medicine. 2001; 30: 370-382. DOI ScienceOn |
| 14 | Chuang CM, Monie A, Wu A, et al., Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects. J Biomed Sci 2009; 16: 49-60. DOI |
| 15 | Ho PC, Saville DJ, Wanwimolruk S. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharm Sci 2001; 4: 217- 227. |
| 16 | Jeong GS, Lee SH, Jeong SN, et al., Anti-inflammatory effects of apigenin on nicotine- and lipopolysaccharidestimulated human periodontal ligament cells via heme oxygenase-1. Int Immunopharmacol 2009; 9: 1374-1380. DOI ScienceOn |
| 17 | Gates MA, Vitonis AF, Tworoger SS, et al., Flavonoid intake and ovarian cancer risk in a population-based case-control study. Int J Cancer 2009; 124: 1918-1925. DOI ScienceOn |
| 18 | Fukuda K, Ohta T, Oshima Y, et al., Specific CYP3A4 inhibitors in grapefruit juice: furocoumarin dimers as components of drug interaction. Pharmacogenetics 1997; 7: 391-396. DOI ScienceOn |
| 19 | Critchfield JW, Welsh CJ, Phang JM, et al., Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol 1994; 48: 1437-1445. DOI ScienceOn |
| 20 | Nguyen H, Zhang S, Morris ME. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. J Pharm Sci 2003; 92; 250-257. DOI ScienceOn |
| 21 | Kimura Y, Ito H, Ohnishi R, et al., Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity. Food Chem Toxicol 2010; 48: 429-435. DOI ScienceOn |
| 22 | Li X, Yun JK, Choi JS. Effects of morin on the pharmacokinetics of etoposide in rats. Biopharm Drug Dispos 2007; 28: 151-156. DOI ScienceOn |
| 23 | Benet LZ, Cummins CL, Wu CY. Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data. Curr Drug Metab 2003; 4: 393- 398. DOI ScienceOn |
| 24 | Cummins CL, Jacobsen W, Benet LZ. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002; 300: 1036-1045. DOI ScienceOn |
| 25 | Kelly PA, Wang H, Napoli KL, et al., Metabolism of cyclosporine by cytochromes P450 3A9 and 3A4. Eur J Drug Metab Pharmacokinet 1999; 24: 321-328. DOI ScienceOn |
| 26 | Cao X, Gibbs ST, Fang L, et al., Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm Res 2006; 23: 1675-1686. DOI ScienceOn |
| 27 | Li X, Choi JS. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Int J Pharm 2007; 337: 188-193. DOI ScienceOn |
| 28 | Li X, Choi JS. Effects of quercetin on the pharmacokinetics of etoposide after oral and intravenouse administration of etoposide in rats. Anticancer Research 2009; 29: 1411-1416. |
| 29 | Piao Y, Shin SC, Choi JS. Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats. Biopharm Drug Dispos 2008; 29: 245-249. DOI ScienceOn |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
